AC
ICPT

Amia Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Amia Capital’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,067
Closed -$382K – 42
2020
Q1 		$382K Sell
6,067
-1,611
-21% -$145K 0.34% 25
2019
Q4 		$951K Buy
+7,678
New +$687K 0.28% 27

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Amia Capital's ICPT Position: Q2 2020 in Review

Amia Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 6,067 shares — an estimated $382K sold.

Amia Capital first reported a position in ICPT in Q4 2019 and held it in 2 quarters. The position peaked at $951K in Q4 2019. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

  • Amia Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Amia Capital sold 6,067 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $382K.
  • Amia Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2019 and held it in 2 quarters.
  • Amia Capital's Intercept Pharmaceuticals, Inc. position peaked at $951K in Q4 2019.
  • 192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Amia Capital's 13F filing for Q2 2020, filed 14 Aug 2020.